These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The conundrum of late and very late stent thrombosis following drug-eluting stent implantation. Garg P; Mauri L Curr Opin Cardiol; 2007 Nov; 22(6):565-71. PubMed ID: 17921745 [TBL] [Abstract][Full Text] [Related]
4. Value and limitations of target-vessel ischemia in predicting late clinical events after drug-eluting stent implantation. Zellweger MJ; Kaiser C; Brunner-La Rocca HP; Buser PT; Osswald S; Weiss P; Mueller-Brand J; Pfisterer ME; J Nucl Med; 2008 Apr; 49(4):550-6. PubMed ID: 18344439 [TBL] [Abstract][Full Text] [Related]
5. Late stent thrombosis with drug-eluting stents: the price to pay to prevent restenosis? Kumbhani DJ; Bavry AA; Bhatt DL Indian Heart J; 2007; 59(2 Suppl B):B113-7. PubMed ID: 19153427 [TBL] [Abstract][Full Text] [Related]
6. [Optimal platelet inhibition after coronary stent implantation. Current status]. Silber S; Hoffmeister HM; Bode C Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073 [TBL] [Abstract][Full Text] [Related]
7. Drug-eluting coronary stents: many meta-analyses, little benefit. Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727 [TBL] [Abstract][Full Text] [Related]
8. Very late thrombosis of drug-eluting stents: a brief literature review and case example. Agarwal SK; Shawl F; Raman VK; Binbrek AS J Invasive Cardiol; 2008 Dec; 20(12):655-8. PubMed ID: 19057030 [TBL] [Abstract][Full Text] [Related]
9. ST-elevated acute myocardial infarction happening 1 month post stent implantation: late thrombosis in-stents or new lesions? Song GY; Yang YJ; Xu B; Li JJ; Gao RL; Qiao SB; Yuan JQ; Tang YD; You SJ; Pei HJ; Zhao ZY; Wang XM; Wu YJ Chin Med J (Engl); 2009 Jul; 122(14):1610-4. PubMed ID: 19719959 [TBL] [Abstract][Full Text] [Related]
10. The safety of drug-eluting stents. Saia F; Marzocchi A; Branzi A Ther Adv Cardiovasc Dis; 2008 Feb; 2(1):43-52. PubMed ID: 19124407 [TBL] [Abstract][Full Text] [Related]
11. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial. Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL; Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853 [TBL] [Abstract][Full Text] [Related]
12. Perioperative management of the patient with a coronary stent. Popescu WM Curr Opin Anaesthesiol; 2010 Feb; 23(1):109-15. PubMed ID: 19901828 [TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications. Qasim A; Cosgrave J; Latib A; Colombo A Am J Cardiol; 2007 Dec; 100(11):1619-24. PubMed ID: 18036358 [TBL] [Abstract][Full Text] [Related]
14. Antiplatelet therapy after implantation of drug-eluting stents: duration, resistance, alternatives, and management of surgical patients. Gurbel PA; DiChiara J; Tantry US Am J Cardiol; 2007 Oct; 100(8B):18M-25M. PubMed ID: 17950828 [TBL] [Abstract][Full Text] [Related]